Johnson & Johnson (NYSE:JNJ) has a long history of lucrative dividends and is also among dividend aristocrats that have increased their dividends over the last 54 consecutive years. There are only a few blue-chips that can …
Johnson & Johnson Shares of healthcare conglomerate Johnson & Johnson (JNJ) began trading ex-dividend on Friday, May 20. To qualify for a dividend check, investors must have owned JNJ shares prior to Friday, which …
In 2013, Johnson & Johnson returned 34%, beating Merck (MRK) and Pfizer’s (PFE) 26% gains but lagging Bristol-Myers Squibb (BMY) 68% gain. RBC analyst Glenn Novarro and team, however, say this could be …
NEW BRUNSWICK, N.J. May 22 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ), the world's leading …
Johnson & Johnson
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. Several firms have issued research on Johnson & Johnson. Many analysts have provided their estimated foresights on …
Johnson & Johnson
15 PM 68 Volume Alert - JNJ Stock 100.60 Johnson & Johnson leahanne 03/31/2015 8:10:34 PM 67 Volume Alert - JNJ Stock 101.55 Johnson & Johnson leahanne 03/30/2015 7:20:01 PM 66 Volume Alert - JNJ Stock
Johnson & Johnson
JNJ reported Q3 earnings last month ... those repurchased shares would have otherwise received. The stock also trades at about 15x earnings, net of excess cash on the balance sheet – an ostensibly fair price to pay. …
Scientists has been wondering for some time now just how safe talcum-based baby powder really is. Yeah, that’s right — the stuff folks sprinkle with abandon on sore baby bottoms. Turns out, when you look at it under a …
Johnson & Johnson posted better-than-expected fourth-quarter 2016 earnings amid lower 2017 forecasts. It also reiterated its aim to look at strategic options that could include mergers or asset sales. Drug major Johnson
One News